Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Post by ngerritson Jul 18, 2013 1:06pm
171 Views
Post# 21615974

VPT - FDA Schedule

VPT - FDA ScheduleThe June 24 PR indicates they need 6-8 weeks to collect/analyze the data required by the FDA.  That puts our re-submission to the FDA between July 26-Aug 9th.  Its anyones guess how long the FDA needs to make a decision, maybe 1 month?  That would put us into early September at the latest.

This weeks trading has lots of nibbles at the ASK but seems like there are always shares for sale at $0.10 so now real movement upward.  With 130 million shares o/s, many holders are sitting on the sidelines waiting for this to move upward as their cost is higher than the current price.

My prediction is some people in the "know" are aware of some news coming and buying up what they can without skyrocketing the SP.  they needed the $$$ quickly from the PP, hence the crappy terms...I suspect it was used to place new units.  if we can get the equipment in more hospitals before september, the SP may move.  With only a few months to go, nobody should be selling at $0.10.
Bullboard Posts